Filing metadata

Accession number
0000950170-24-051487
Form type
Form 3
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
May 01, 2024
Reporting period
Apr 29, 2024
Description
Initial ownership

Explore SEC Filings Hub